1. Epstein - Barr virus - associated lymphoid proliferations, a 2018 update
    Sherif A. Rezk et al, 2018, Human Pathology CrossRef
  2. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
    Rou-Jun Peng et al, 2018, Leukemia CrossRef
  3. New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015
    J. Han van Krieken, 2016, J Hematopathol CrossRef
  4. Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
    Qingqing Cai et al, 2019, Front. Oncol. CrossRef
  5. Non-coding RNAs in Natural Killer/T-Cell Lymphoma
    Mei Mei et al, 2019, Front. Oncol. CrossRef
  6. EBV–Associated Lymphoproliferative Disorders
    Sherif A. Rezk et al, 2019, Surgical Pathology Clinics CrossRef
  7. A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway
    Yuan Mao et al, 2017, Oncotarget CrossRef
  8. The landscape of new drugs in extranodal NK/T-cell lymphoma
    Liang Wang et al, 2020, Cancer Treatment Reviews CrossRef
  9. Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs
    Kotaro Miyao et al, 2018, Cancer Immunol Res CrossRef
  10. Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma
    Hanqing Wang et al, 2021, Virus Genes CrossRef
  11. The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins.
    Yang Wang et al, 2021, BMC Cancer CrossRef
  12. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
    Ajay Major et al, 2023, Cancers CrossRef
  13. EBV and Lymphomagenesis
    Daniel G. Sausen et al, 2023, Cancers CrossRef
  14. Novel target and treatment agents for natural killer/T-cell lymphoma
    Xiao-Peng Tian et al, 2023, J Hematol Oncol CrossRef
  15. Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma
    Linyan Xu et al, 2023, J Pharmacol Exp Ther CrossRef
  16. Treatment of Epstein-Barr Virus infection in immunocompromised patients
    Martyna Pociupany et al, 2024, Biochemical Pharmacology CrossRef
  17. null
    Yuan Tan et al, 2024 CrossRef